{"id":480428,"date":"2023-12-10T19:19:02","date_gmt":"2023-12-11T03:19:02","guid":{"rendered":"https:\/\/nai500.com\/?p=480428"},"modified":"2023-12-10T19:19:02","modified_gmt":"2023-12-11T03:19:02","slug":"%e9%87%8d%e5%a4%a7%e5%88%a9%e5%a5%bd%e5%85%91%e7%8e%b0-cf%e8%8d%af%e7%89%a9%e7%9a%84%e9%9c%b8%e4%b8%bb-%e5%ae%9e%e5%8a%9b","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2023\/12\/%e9%87%8d%e5%a4%a7%e5%88%a9%e5%a5%bd%e5%85%91%e7%8e%b0-cf%e8%8d%af%e7%89%a9%e7%9a%84%e9%9c%b8%e4%b8%bb-%e5%ae%9e%e5%8a%9b\/","title":{"rendered":"\u91cd\u5927\u5229\u597d\u5151\u73b0\uff0cCF\u836f\u7269\u7684\u9738\u4e3b\u7528\u884c\u52a8\u8bc1\u660e\u4e86\u81ea\u5df1\u7684\u5b9e\u529b"},"content":{"rendered":"<p>\u5927\u578b\u751f\u7269\u79d1\u6280\u516c\u53f8<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=VRTX\">\u798f\u6cf0\u5236\u836fVertex Pharmaceuticals\uff08NASDAQ:VRTX\uff09<\/a>\u5df2\u7ecf\u5efa\u7acb\u4e86\u4e00\u4e2a\u5341\u4ebf\u7f8e\u5143\u89c4\u6a21\u7684\u56ca\u6027\u7ea4\u7ef4\u5316\uff08CF\uff09\u6cbb\u7597\u836f\u7269\u5e1d\u56fd\uff0c\u4f46\u6295\u8d44\u8005\u4e00\u76f4\u671f\u5f85\u8be5\u516c\u53f8\u80fd\u591f\u5b9e\u73b0\u5176\u4ed6\u6cbb\u7597\u9886\u57df\u7684\u81ea\u6211\u7a81\u7834\uff0c\u84c4\u529b\u957f\u671f\u589e\u957f\u3002<\/p>\n<p>2020\u5e74\u548c2021\u5e74\uff0c\u798f\u6cf0\u5236\u836f\u7684\u4e24\u6b3e\u6cbb\u7597\u03b11-\u6297\u80f0\u86cb\u767d\u9176\u7f3a\u4e4f\u75c7\uff08AATD\uff09\u7684\u5019\u9009\u836f\u7269\u5ba3\u544a\u5931\u8d25\uff0c\u80a1\u4ef72021\u5e74\u6700\u4f4e\u70b9\u65f6\u66b4\u8dcc\u7ea635%\u3002\u4e0d\u8fc7\u6700\u8fd1\uff0c\u8be5\u516c\u53f8\u8054\u5408CRISPR Therapeutics AG\uff08NASDAQ:CRSP\uff09\u5f00\u53d1\u7684\u9570\u72b6\u7ec6\u80de\u75c5\uff08SCD\uff09\u57fa\u56e0\u7f16\u8f91\u7597\u6cd5exa-cel\uff08\u5546\u54c1\u540dCasgevy\uff09\u83b7\u6279\u4e0a\u5e02\u9500\u552e\uff0c\u6295\u8d44\u8005\u7684\u671f\u5f85\u4e5f\u7ec8\u4e8e\u7ed3\u6210\u6b63\u679c\u3002<\/p>\n<h2>\u798f\u6cf0\u5236\u836f\uff1aCF\u9886\u57df\u7684\u9738\u4e3b<\/h2>\n<p>\u5148\u6765\u8bf4\u8bf4\u798f\u6cf0\u5236\u836f\u7684\u56ca\u6027\u7ea4\u7ef4\u5316\u836f\u7269\u3002\u8be5\u516c\u53f8\u6700\u7545\u9500\u7684\u836f\u7269Trikafta\u7684\u4e13\u5229\u4fdd\u62a4\u671f\u5ef6\u7eed\u81f32037\u5e74\uff0c\u540c\u65f6\u5176\u4ed6\u7597\u6548\u66f4\u597d\uff0c\u7ed9\u836f\u66f4\u65b9\u4fbf\u7684CF\u5019\u9009\u836f\u7269\u7684\u5173\u952e\u8bd5\u9a8c\u4e5f\u5728\u8fdb\u884c\u4e2d\u3002\u6b64\u5916\uff0c\u9488\u5bf9\u5269\u4f59\u4e00\u5c0f\u90e8\u5206\u76ee\u524d\u65e0\u836f\u53ef\u533b\u7684\u56ca\u6027\u7ea4\u7ef4\u5316\u60a3\u8005\uff0c\u8be5\u516c\u53f8\u8054\u624bModerna Inc.\uff08NASDAQ:MRNA\uff09\u542f\u52a8\u4e86\u5019\u9009\u836f\u7269\u7684\u4e34\u5e8a\u8bd5\u9a8c\u3002\u53bb\u5e74\uff0cCF\u836f\u7269\u4e3a\u798f\u6cf0\u5236\u836f\u521b\u9020\u4e8689\u4ebf\u7f8e\u5143\u7684\u6536\u5165\uff0c\u5176\u4e2dTrikafta\u5360\u4e8687%\u3002<\/p>\n<p>\u518d\u6765\u8bf4\u8bf4Casgevy\u3002\u7f8e\u56fd\u6279\u51c6\u4e4b\u524d\u7684\u51e0\u5468\uff0c\u82f1\u56fd\u5168\u7403\u7b2c\u4e00\u4e2a\u6279\u51c6\u8fd9\u4e00\u57fa\u4e8eCRISPR\u7684\u57fa\u56e0\u7f16\u8f91\u7597\u6cd5\u6cbb\u7597\u9570\u72b6\u7ec6\u80de\u548c\u03b2\u5730\u4e2d\u6d77\u8d2b\u8840\u3002\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u8ba1\u5212\u660e\u5e743\u6708\u516c\u5e03Casgevy \u03b2\u5730\u4e2d\u6d77\u8d2b\u8840\u9002\u5e94\u75c7\u7684\u5ba1\u6279\u51b3\u5b9a\u3002\u6b64\u5916\uff0c\u6b27\u76df\u7684\u5ba1\u6279\u51b3\u5b9a\u4e5f\u5728\u8fdb\u884c\u5f53\u4e2d\u3002Casgevy\u7684\u4ef7\u683c\u867d\u7136\u9ad8\u8fbe220\u4e07\u7f8e\u5143\uff0c\u4f46\u7531\u4e8e\u662f\u4e00\u6b21\u6027\u529f\u80fd\u6027\u6cbb\u6108\u65b9\u6848\uff0c\u56e0\u6b64\u4f9d\u7136\u5907\u53d7\u5173\u6ce8\u3002<\/p>\n<h2>Casgevy\u5373\u5c06\u4e0a\u5e02<\/h2>\n<p>\u798f\u6cf0\u5236\u836f\u7684Casgevy\u9a6c\u4e0a\u5c31\u5c06\u4e0a\u5e02\u9500\u552e\uff0c\u5e76\u4e14\u5df2\u7ecf\u5728\u7f8e\u56fd\u8bbe\u7acb\u4e869\u5bb6\u6388\u6743\u6cbb\u7597\u4e2d\u5fc3\uff0c\u6f5c\u5728\u60a3\u8005\u4eba\u6570\u7ea6\u4e3a1.6\u4e07\u3002\u6309\u7167\u9ad8\u76db\u7684\u9884\u6d4b\uff0cCasgevy\u7684\u5cf0\u503c\u6536\u5165\u4e3a39\u4ebf\u7f8e\u5143\u3002FDA\u6279\u51c6\u4e4b\u540e\uff0c\u798f\u6cf0\u5236\u836f\u5c06\u5411CRISPR Therapeutics\u652f\u4ed82.00\u4ebf\u7f8e\u5143\u7684\u91cc\u7a0b\u7891\u6b3e\uff0c\u5e76\u4e14\u6309\u7167\u5206\u6210\u534f\u8bae\uff0c\u516c\u53f8\u5c06\u4fdd\u7559\u8be5\u4ea7\u54c160%\u7684\u5229\u6da6\u3002<\/p>\n<p>\u56e0\u6b64\uff0cCasgevy\u7684\u6536\u5165\u867d\u7136\u65e0\u6cd5\u8fbe\u5230CF\u4ea7\u54c1\u7ec4\u5408\uff0c\u751a\u81f3\u662fTrikafta\u7684\u6c34\u5e73\uff0c\u4f46\u610f\u4e49\u91cd\u5927\uff0c\u8bf4\u660e\u8be5\u516c\u53f8\u6709\u80fd\u529b\u62d3\u5c55\u65b0\u7684\u6536\u5165\u6e90\u3002\u6b64\u5916\uff0c\u798f\u6cf0\u5236\u836f\u7684\u5176\u4ed6\u975eCF\u4ea7\u54c1\u53ef\u80fd\u4e5f\u5c06\u5f88\u5feb\u9762\u4e16\u3002\u6bd4\u5982\u8bf4\uff0c\u8be5\u516c\u53f8\u5df2\u7ecf\u5b8c\u6210\u4e86\u75bc\u75db\u7ba1\u7406\u5019\u9009\u4ea7\u54c1\u7684\u5173\u952e\u8bd5\u9a8c\uff0c\u9884\u8ba1\u660e\u5e74\u521d\u53d1\u5e03\u7ed3\u679c\u3002<\/p>\n<h2>\u80a1\u7968\u6027\u4ef7\u6bd4\u5f88\u9ad8<\/h2>\n<p>\u867d\u7136\u4eca\u5e74\u80a1\u4ef7\u51fa\u73b0\u4e86\u4e24\u4f4d\u6570\u7684\u4e0a\u6da8\uff0c\u4f46\u798f\u6cf0\u5236\u836f\u80a1\u7968\u76ee\u524d\u7684\u52a8\u6001\u5e02\u76c8\u7387\u4f9d\u7136\u53ea\u670923\u3002\u8003\u8651\u5230\u8be5\u516c\u53f8\u7a33\u5b9a\u7684\u5341\u4ebf\u7f8e\u5143\u7ea7\u522b\u7684\u76c8\u5229\u589e\u957f\uff0c\u8be5\u9886\u57df\u5185\u6301\u4e45\u7684\u7ba1\u7406\u56e2\u961f\uff0c\u4ee5\u53ca\u73b0\u5728\u8be5\u516c\u53f8\u8bc1\u660e\u81ea\u5df1\u6709\u80fd\u529b\u62d3\u5c55\u5176\u4ed6\u6cbb\u7597\u9886\u57df\uff0c\u8fd9\u4e00\u4f30\u503c\u6c34\u5e73\u7684\u6027\u4ef7\u6bd4\u5f88\u9ad8\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u5927\u578b\u751f\u7269\u79d1\u6280\u516c\u53f8\u798f\u6cf0\u5236\u836fVertex Pharmaceuticals\uff08NASDAQ:VRTX\uff09\u5df2\u7ecf\u5efa\u7acb\u4e86\u4e00\u4e2a\u5341 [&hellip;]<\/p>\n","protected":false},"author":27,"featured_media":480429,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1521,430],"tags":[455,747,2155,925],"class_list":["post-480428","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1521","category-trends-strategies-zh-hans","tag-455","tag-747","tag-2155","tag-925","sectors-life-science-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/480428","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=480428"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/480428\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/480429"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=480428"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=480428"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=480428"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}